cognitive cybersecurity intelligence
On May 10, the FDA released two discussion papers on the use of artificial intelligence and machine learning (AI/ML) in drug development and manufacturing. In a statement introducing the papers, Patrizia Cavazzoni, M.D., Director of the FDA Center for Drug Evaluation and Research,…
Source: www.medtechintelligence.com – Read more
Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.
Brockton hospital hit by cybersecurity incident, services affected wcvb.com
Yuzu’s $35 million round was led by General Catalyst and Chemistry, with participation from Anthropic’s Anthology Fund, Bain Future Back Ventures, Timeless Ventures, Lachy Groom
TrojAI has extended its platform for securing artificial intelligence (AI) applications, tools and platforms to now include a red teaming capability that is performed by
Register Now Panelists: Rodolphe Barrangou, PhD North Carolina State University View Bio Panelist Rodolphe Barrangou, PhD Rodolphe Barrangou, PhD, is the T. R. Klaenhammer Distinguished
